Effects of prolonged ethanol lock exposure to carbothane- and silicone-based hemodialysis catheters: A 26-week study

Journal of Vascular Access

Volumn 16, Issue 5, 2015, Pages 367-371

  Landry, Daniel L ^a,b   Jaber, Randa A ^a,b   Hanumanthappa, Nandheesha ^a,b   Lipkowitz, George S ^a,b   O’Shea, Michael H ^a,b   Bermudez, Harry ^c   Hathorne, Adam P ^c   Braden, Gregory L ^a,b  

^a BAYSTATE MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Catheters; Ethanol; Hemodialysis; Lock

Indexed keywords

ALCOHOL; CARBOTHANE; HEPARIN; POLYURETHAN; SILICONE; UNCLASSIFIED DRUG; ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; SILICONE DERIVATIVE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; CONTROLLED STUDY; DIALYSIS CATHETER; HEMODIALYSIS; MECHANICS; SCANNING ELECTRON MICROSCOPY; YOUNG MODULUS; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CHEMISTRY; COMPARATIVE STUDY; DEVICE FAILURE ANALYSIS; DEVICES; INDWELLING CATHETER; MATERIALS TESTING; MECHANICAL STRESS; MICROBIOLOGY; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RENAL REPLACEMENT THERAPY; TIME FACTOR; VASCULAR ACCESS DEVICE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTICOAGULANTS; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; ELASTIC MODULUS; EQUIPMENT FAILURE ANALYSIS; ETHANOL; HEPARIN; MATERIALS TESTING; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RENAL DIALYSIS; SILICONES; STRESS, MECHANICAL; TIME FACTORS; VASCULAR ACCESS DEVICES;

EID: 84943251072     PISSN: 11297298     EISSN: 17246032     Source Type: Journal    
DOI: 10.5301/jva.5000397     Document Type: Article

References (32)

1. U.S. Renal Data System. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013.
2. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779-791.
3. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620-626.
4. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant. 2008;23(5):1666-1672.
5. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A metaanalysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis. 2008; 51(2):233-241.
6. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47(1):83-93.
7. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med. 2008;148(8):596-605.
8. Rabindranath KS, Bansal T, Adams J, et al. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant. 2009;24(12): 3763-3774.
9. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol. 2010;5(10):1799-1804.
10. Abbas SA, Haloob IA, Taylor SL, et al. Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report. Am J Kidney Dis. 2009;53(3):492-502.
11. Dixon JJ, Steele M, Makanjuola AD. Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study. Nephrol Dial Transplant. 2012;27(9):3575-3581.
12. Maiefski M, Rupp ME, Hermsen ED. Ethanol lock technique: review of the literature. Infect Control Hosp Epidemiol. 2009;30(11):1096-1108.
13. Ackoundou-N'guessan C, Heng A-E, Guenu S, et al. Ethanol lock solution as an adjunct treatment for preventing recurrent catheter-related sepsis-first case report in dialysis setting. Nephrol Dial Transplant. 2006;21(11):3339-3340.
14. Crnich CJ, Halfmann JA, Crone WC, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol. 2005;26(8):708-714.
15. Askeland D, Fulay P, Wright W. The science and engineering of materials. Stamford, CT, USA: Cengage Learning; 2010.
16. Guenu S, Heng AE, Charbonné F, et al. Mass spectrometry and scanning electron microscopy study of silicone tunneled dialysis catheter integrity after an exposure of 15 days to 60% ethanol solution. Rapid Commun Mass Spectrom. 2007;21(2): 229-236.
17. Msakni N, Galmier MJ, Couret MJ, et al. Complementary mass spectrometric approaches and scanning electron microscopy to study the structural stability of polyurethane tunneled dialysis catheters after exposure to ethanol solutions. Rapid Commun Mass Spectrom. 2013;27(21):2343-2354.
18. Pennington CR, Pithie AD. Ethanol lock in the management of catheter occlusion. JPEN J Parenter Enteral Nutr. 1987; 11(5):507-508.
19. Dannenberg C, Bierbach U, Rothe A, Beer J, Körholz D. Ethanollock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol. 2003;25(8):616-621.
20. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2007;31(4):302-305.
21. Mouw E, Chessman K, Lesher A, Tagge E. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg. 2008;43(6):1025-1029.
22. Broom J, Woods M, Allworth A, et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis. 2008;40(5):399-406.
23. Slobbe L, Doorduijn JK, Lugtenburg PJ, et al. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One. 2010;5(5):e10840.
24. Kayton ML, Garmey EG, Ishill NM, et al. Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent Mediport catheter-related bloodstream infections. J Pediatr Surg. 2010;45(10):1961-1966.
25. Cober MP, Kovacevich DS, Teitelbaum DH. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. JPEN J Parenter Enteral Nutr. 2011;35(1):67-73.
26. Abu-El-Haija M, Schultz J, Rahhal RM. Effects of 70% ethanol locks on rates of central line infection, thrombosis, breakage, and replacement in pediatric intestinal failure. J Pediatr Gastroenterol Nutr. 2014;58(6):703-708.
27. McHugh GJ, Wild DJ, Havill JH. Polyurethane central venous catheters, hydrochloric acid and 70% ethanol: a safety evaluation. Anaesth Intensive Care. 1997;25(4):350-353.
28. Schilcher G, Schlagenhauf A, Schneditz D, et al. Ethanol causes protein precipitation-new safety issues for catheter locking techniques. PLoS One. 2013;8(12):e84869.
29. Mermel LA, Alang N. Adverse effects associated with ethanol catheter lock solutions: a systematic review. J Antimicrob Chemother. 2014;69(10):2611-2619.
30. Bell AL, Jayaraman R, Vercaigne LM. Effect of ethanol/trisodium citrate lock on the mechanical properties of carbothane hemodialysis catheters. Clin Nephrol. 2006;65(5):342-348.
31. Vercaigne LM, Takla TA, Raghavan J. Long-term effect of an ethanol/ sodium citrate locking solution on the mechanical properties of hemodialysis catheters. J Vasc Access. 2010;11(1):12-16.
32. Agraharkar M. Failure of central vein catheters after prolonged use. Semin Dial. 2000;13(3):205-206.